Literature DB >> 3207970

Inhibitory effect of 1,2,3,4-tetrahydro-9-aminoacridine on the depolarization-induced release of GABA from cerebral cortex.

J de Belleroche1, I M Gardiner.   

Abstract

1,2,3,4-Tetrahydro-9-aminoacridine (THA) has an inhibitory effect on the activity of acetylcholinesterase which has led to its use in the treatment of Alzheimer's disease. Other actions of THA include the inhibition of voltage-dependent ion channels. In this paper we describe the effect of THA on the depolarization-induced release of [14C]-gamma-aminobutyric acid (GABA) from tissue slices of rat cerebral cortex. THA produced a dose-dependent inhibition of the 30 mM K+-evoked release of [14C]-GABA with an IC50 of 56 microM. The maximal response was an 84% inhibition of the evoked response. THA (up to a concentration of 1 mM) had no effect on the basal release of GABA. A similar inhibitory effect on the K+-evoked release of [14C]-GABA was seen with 4-aminopyridine (4-AP) but no inhibition was obtained with tetraethylammonium up to a concentration of 20 mM. The maximal inhibitory effect of 4-AP (39%) occurred at 1 mM (IC50 of 112 microM) and this response was much smaller in magnitude than that obtained with THA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207970      PMCID: PMC1854078          DOI: 10.1111/j.1476-5381.1988.tb11615.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current.

Authors:  B Drukarch; K S Kits; E G Van der Meer; J C Lodder; J C Stoof
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

2.  Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons.

Authors:  M A Rogawski
Journal:  Eur J Pharmacol       Date:  1987-10-06       Impact factor: 4.432

3.  Anticonvulsants and trifluoperazine inhibit the evoked release of GABA from cerebral cortex of rat at different sites.

Authors:  J de Belleroche; A Dick; A Wyrley-Birch
Journal:  Life Sci       Date:  1982-12-20       Impact factor: 5.037

4.  The effect of 4-aminopyridine on acetylcholine release.

Authors:  E S Vizi; J van Dijk; F F Foldes
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.

Authors:  J de Belleroche; I M Gardiner
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

6.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

Authors:  W K Summers; L V Majovski; G M Marsh; K Tachiki; A Kling
Journal:  N Engl J Med       Date:  1986-11-13       Impact factor: 91.245

  6 in total
  4 in total

1.  Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats.

Authors:  L A Dawson; C Routledge
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.

Authors:  M Diez-Ariza; C Redondo; M García-Alloza; B Lasheras; J Del Río; M J Ramírez
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

3.  Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses.

Authors:  H A Baldwin; R J De Souza; G S Sarna; T K Murray; A R Green; A J Cross
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.